Elicio Therapeutics, Inc. (ELTX)
NASDAQ: ELTX · Real-Time Price · USD
6.45
+0.12 (1.90%)
Jan 21, 2025, 4:00 PM EST - Market closed
Elicio Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Jan '25 Jan 21, 2025 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 70 | 80 | - | - | - | - |
| Enterprise Value | 70 | 72 | - | - | - | - |
| Last Close Price | 6.45 | 8.34 | - | - | - | - |
| PB Ratio | -2.85 | 7.04 | - | - | - | - |
| P/TBV Ratio | - | 7.04 | - | - | - | - |
| Debt / Equity Ratio | -1.37 | 0.61 | 0.84 | -2.88 | 0.03 | 0.13 |
| Quick Ratio | 2.88 | 1.32 | 0.90 | 0.49 | 4.53 | 3.90 |
| Current Ratio | 3.40 | 1.67 | 1.56 | 0.55 | 4.67 | 4.15 |
| Return on Equity (ROE) | - | -346.95% | -1170.93% | -430.76% | -136.60% | - |
| Return on Assets (ROA) | -73.70% | -89.70% | -79.16% | -92.36% | -68.96% | - |
| Return on Capital (ROIC) | -185.90% | -128.82% | -123.12% | -130.00% | -80.83% | - |
| Earnings Yield | -67.39% | -43.93% | - | - | - | - |
| FCF Yield | -55.04% | -40.89% | - | - | - | - |
| Buyback Yield / Dilution | -264.13% | -1500.08% | 97.93% | -42.39% | -172.21% | - |
| Total Shareholder Return | -264.13% | -1500.08% | 97.93% | -42.39% | -172.21% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.